Enhancement of the antitumor activity of ionising radiation by nimotuzumab, a humanised monoclonal antibody to the epidermal growth factor receptor, in non-small cell lung cancer cell lines of differing epidermal growth factor receptor status.

Source:http://linkedlifedata.com/resource/pubmed/id/18253126

Br. J. Cancer 2008 Feb 26 98 4 749-55

Download in:

View as

General Info

PMID
18253126